ARTICLE | Company News
Roche, Kyowa Hakko Kogyo Co. Ltd. deal
November 24, 1997 8:00 AM UTC
Roche received exclusive worldwide marketing rights, excluding Japan, from Kyowa Hakko to an adenosine A2 receptor antagonist to treat Parkinson's disease. The companies will jointly develop the comp...